1. Lin J#, Peng X#, Dong K#, Long J#, Guo X, Li H, Bai Y, Yang X, Wang D, Lu X, Mao Y, Sang X, Ji X, Zhao H*, Liang H*.Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer. Nature Communications. 2021 Aug 6;12(1):4753. (IF=14.919)
2. Long J#, Huang S#, Bai Y#, Mao J#, Wang A, Lin Y, Yang X, Wang D, Lin J, Bian J, Yang X, Sang X*, Wang X*, Zhao H*. Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis., Brief Bioinform, 2021, 20(22): 224. (IF=11.622)
3. Yang X#, Hu Y#, Yang K#, Wang D#, Lin J, Long J, Xie F, Mao J, Bian J, Guan M, Pan J, Huo L, Hu K, Yang X, Mao Y, Sang X, Zhang J, Wang X*, Zhang H*, Zhao H*. Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers. J Immunother Cancer. 2021 May;9(5):e001942. (IF=13.751)
4. Lin J#, Cao Y#, Yang X#, Li G, Shi Y, Wang D, Long J, Song Y, Mao J, Xie F, Bai Y, Zhang L, Yang X, Wan X, Wang A, Guan M, Zhao L, Hu K, Pan J, Huo L, Lu X, Mao Y, Sang X, Zhang H*, Wang K*, Wang X*, Zhao H*.Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics. 2021 Mar 4;11(10):4585-4598 . (IF=11.556)
5. Lin J#, Shi J#, Guo H#, Yang X, Jiang Y, Long J, Bai Y, Wang D, Yang X, Wan X, Zhang L, Pan J, Hu K, Guan M, Huo L, Sang X, Wang K*, Zhao H*.Alterations in DNA Damage Repair Genes in Primary Liver Cancer. Clin Cancer Res. 2019 Aug 1;25(15):4701-4711. (IF=10.107)
6. Long J#, Wang A#, Bai Y#, Lin J, Yang X, Wang D, Yang X, Jiang Y, Zhao H*. Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. EBioMedicine. 2019 Apr;42:363-374. (IF=8.143, ESI)
7. Wang A#, Wu L#, Lin J#, Han L, Bian J, Wu Y, Robson SC, Xue L, Ge Y, Sang X*, Wang W*, Zhao H*.Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma. Nature Communications. 2018 Mar 1;9(1):894. (IF=11.878)
8. Long J#, Lin J#, Wang A#, Wu L, Zheng Y, Yang X, Wan X, Xu H, Chen S, Zhao H. PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy. J Hematol Oncol. 2017 Aug 3;10(1):146. (IF=7.333)
9. Yang Z, Wu L, Wang A, Tang W, Zhao Y, Zhao H*, Teschendorff AE*. dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers. Nucleic Acids Res. 2017 Jan 4;45(D1):D812-D818. (IF=11.162)
10. Long J#, Lin J#, Wang A#, Wu L, Zheng Y, Yang X, Wan X, Xu H*, Chen S*, Zhao H*.Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis. Journal of Hepatology 2014 Oct;61(4):840-849. (IF=11.336)
